Search
New Jersey-based pharmaceutical giant Merck & Co. (NYSE:MRK) is reportedly ready to pay over an estimated $500 million to acquire private ... ... <看更多>
#1. Merck to Acquire SmartCells, Inc.
they have entered into a definitive agreement under which Merck will acquire SmartCells, a private company developing a glucose responsive
#2. Merck ($MRK) to buy SmartCells in $500M deal | Fierce Biotech
With an eye on remaining one of the leaders in the diabetes field, Merck ($MRK) has agreed to pay more than $500 million in upfront fees and potential ...
#3. Merck to Acquire SmartCells, Inc. - Fierce Pharma
Under the terms of the agreement, Merck will acquire all outstanding stock of SmartCells, Inc. In return SmartCells shareholders will receive an upfront ...
#4. The half-billion-dollar idea | MIT News | Massachusetts ...
It worked: Seven years later, Merck & Co. acquired SmartCells and the license for SmartInsulin for a substantial upfront sum and milestone ...
#5. Merck acquires diabetes specialist SmartCells for smart ...
Pharma giant Merck will acquire SmartCells, a private company developing a smart, glucose-responsive insulin formula to treat diabetes.
#6. Merck to buy SmartCells to gain diabetes product - Reuters
Merck & Co plans to buy privately held SmartCells Inc, whose main technology was developed at the Massachusetts Institute of Technology and ...
#7. Merck Purchases SmartCells – Wow, an Insulin (Maybe) That ...
In late 2010, Merck announced that it had acquired SmartCells, a small Massachusetts-based company that is developing a smart insulin ...
#8. Merck to Acquire SmartCells, Inc - World Pharma Today
Merck & Co., Inc., and SmartCells, Inc., announced that they have entered into a definitive agreement under which Merck will acquire SmartCells, ...
#9. Merck to acquire SmartCells, Inc. - IndiaInfoline
Merck will acquire all outstanding stock of SmartCells, Inc. In return SmartCells shareholders will receive an upfront cash payment and be eligible to ...
#10. Merck Set to Buy Biotech Firm SmartCells - CHEManager
U.S. pharmaceutical company Merck & Co. is set to buy SmartCells Inc, a privately held biotechnology firm in the early stages of developing a new diabetes ...
#11. Merck & Co. to Acquire SmartCells and its Glucose ...
SmartCells, a privately held insulin developer, has received a buyout offer from Merck & Co. that is potentially worth more than US$500 M if ...
#12. SmartCells, Smart Story: Lean Biotech, Large Return - Forbes
Merck recently announced in its 2010 10K that it determined that SmartCells had a “fair value at the acquisition date of $138M” including ...
#13. Merck to acquire SmartCells for USD 500 mn
Drug-maker Merck & Co has announced that it will buy biotechnology company SmartCells for USD 500 million.
#14. Merck & Co. to Take Over SmartCells for Platform that Auto ...
Merck & Co. is acquiring SmartCells, a private company developing a glucose-responsive insulin formulation for the treatment of diabetes ...
#15. SmartCells - Crunchbase Company Profile & Funding
SmartCells develops insulin and polymer-based products for the treatment of diabetes, ... SmartCells was acquired by Merck for $500M on Dec 2, 2010 .
#16. SmartCells CEO reflects on strategy with Merck - Boston.com
But last week the drug giant Merck made headlines with its plans to buy SmartCells for upfront and potential milestone payments of more than ...
#17. Merck to acquire SmartCells, a JDRF-funded co - EurekAlert!
NEW YORK – Today pharmaceutical company, Merck & Co., Inc. announced it will acquire SmartCells, Inc., a private biotech developing a ...
#18. Merck to acquire SmartCells for $500 mn - The Indian Express
Drug-maker Merck & Co has announced that it will buy biotechnology company SmartCells for USD 500 million. Merck has a significant presence ...
#19. SmartCells, Inc. - LinkedIn
Biotechnology Research · Report · Report · About us · Locations · Employees at SmartCells, Inc. · Similar pages · Browse jobs ...
#20. Merck to Acquire SmartCells, Inc. | More News
Merck & Co. and SmartCells announced that they have entered into a definitive agreement under which Merck will acquire SmartCells, ...
#21. Merck to Acquire SmartCells,Developer of Diabetes Treatments
Merck & Co. and SmartCells Inc. Dec. 2 announced that they have entered into a definitive agreement under which Merck will acquire ...
#22. The SmartCells Story
December 2010, Merck and Co. acquired SmartCells for over $500M in cash and clinical milestone payments. Dr. Zion developed the SmartInsulin™ technology as ...
#23. Merck Buyout of SmartCells Could Exceed $500M - Xconomy
Beverly, MA-based biotech startup SmartCells has found a big corporate buyer. Merck & Co. (NYSE:]), the Whitehouse Station, NJ-based drug ...
#24. Merck to buy insulin developer SmartCells | Crain's New York ...
Drugmaker Merck & Co. says it will buy insulin developer SmartCells in a deal that may exceed $500 million if development and regulatory ...
#25. Repeat Founder Todd Zion, PhD, "Magical Proteins"
Repeat biotech founder Todd Zion on SmartCells (acquired by Merck for $500MM) and his current venture Akston Bio which is doing cool things ...
#26. Review: Glucose-sensitive insulin - ScienceDirect.com
It is conceivable that SmartCells/Merck had plans to initially test the concept in humans and planned to later address the pharmacokinetic issues, ...
#27. merck-smartcells-update - SlideShare
Merck Statement on SmartCells Provided on March 15, 2012 by Nancy Thornberry, Senior Vice President and Research Head, Diabetes and Endocr…
#28. Merck to Buy Biotech Company Developing Diabetes Drug
The deal for SmartCells Inc. would exceed $500 million if various milestones for development, regulatory approval and sales are met, ...
#29. Company - Akston Biosciences
It is led by the team at SmartCells, Inc. that developed SmartInsulin and sold it to Merck & Co. in one of the largest preclinical pharmaceutical ...
#30. SmartCells | Tracxn
SmartCells | Founded by Todd Zion in the year 2003 · Glucose-regulated injectable formulation for treating ... SmartCells was acquired by Merck in 2010.
#31. Novo Nordisk Buys British 'Smart' Insulin Diabetes Biotech for ...
For example, in 2010, US startup SmartCells was bought by Merck & Co for $500M (€439M) to bring its smart insulin drug candidate into ...
#32. Newsflash: Merck to buy insulin developer SmartCells Inc.
Merck to buy insulin developer SmartCells Inc. in a deal that may exceed $500 million if development and regulatory milestones are met.
#33. Merck smart insulin project advancing into clinical trials - JDRF
SmartCells — a diabetes drug-development company that received early support from JDRF — was founded in 2003 by Todd Zion, Ph.D., ...
#34. Merck moves into insulin with biotech deal - Financial Times
Nancy Thornberry, senior vice-president for diabetes and obesity research, said of the SmartCells deal: “If this investigational technology is ...
#35. Juvenile Diabetes Cure Alliance- JDCA - Facebook
My nephew went to high school with a young man who was one of the first people in the trials. He LOVED it. That was when it was owned by SmartCells Inc. Merck ...
#36. Merck & Co to buy insulin company in $500 million deal
Merck & Co has announced that it will acquire SmartCells, a private company based in Massachusetts which is developing a glucose-responsive ...
#37. NJ's Merck strengthens ability to treat diabetes with acquisition ...
The acquisition of Massachusetts-based SmartCells has the potential to ... The drug company Merck said it will acquire SmartCells Inc., ...
#38. Merck Enters The Alzheimer's Disease Race, Plans Filings For ...
As Merck heads into a “patent cliff” year, highlights of its ... start up SmartCells, which Merck acquired in 2010 (Also see "Merck Adds To ...
#39. Todd Zion
Zion founded SmartCells, Inc. to develop SmartInsulin, the world's first glucose-regulated insulin for treating diabetes. In December 2010, Merck and Co.
#40. Merck to buy Beverly company for $500M - Salem News
The Beverly company, SmartCells, was founded by a doctoral student at the Massachusetts Institute for Technology in 2003 and moved into Cummings ...
#41. SmartCells Company Profile: Acquisition & Investors | PitchBook
Developer of insulin products. The company offers SmartInsulin, a self regulating injectable formulation for treating diabetes. ... Merck & Co. Primary Office.
#42. Angel Invest Boston: Todd Zion, PhD, Repeat Founder
Join Sal's Investment Syndicate List: Click to Join Repeat biotech founder Todd Zion on SmartCells (acquired by Merck for $500MM) and his current venture ...
#43. Beverly Bio-Pharm Sold to Merck - CBS Boston
Just 7 years after launching the company, privately-held SmartCells of Beverly will be sold to Merck Pharmaceuticals for as much as $500 ...
#44. Akston Biosciences Announces Commercial Supply ...
Founded by the team that developed the world's first clinical glucose-responsive insulin at SmartCells, Inc. (sold to Merck & Co.) ...
#45. Patents Assigned to SmartCells, Inc.
Applicants: Merck Sharp & Dohme Corp., SmartCells, Inc. Inventors: Lin Yan, Pei Huo, Ahmet Kekec, Yuping Zhu, Dmitri Pissarnitski, Danqing D. Feng, ...
#46. FLASH REPORT: Smart Insulin Ready for Human Trials
The Merck project appears to be the most advanced smart insulin initiative in development. It began as. SmartCells, Inc., a 14-person ...
#47. SmartCells — Keiretsu Capital Partners
The company was acquired by Merck & Company (NSYE:MRK) for $500 million on December 3, 2010. The company is no longer actively tracked by PitchBook.
#48. Value Creation - RRD International
Value Created: SmartCells was acquired by Merck & Co. in a deal valued at more than $500M. Asset: Platform technology in endocrine disorders.
#49. Portfolio Exits - Cherrystone Angel Group
Sales-based payments for products resulting from the transaction will also be payable. In 2010, SmartCells, Inc. was acquired by Merck. BoardOnTrack.
#50. Todd Zion, Owner, Co-founder, CEO, President - eMedEvents
In December 2010, Merck and Co. acquired SmartCells for over $500M in cash and clinical milestone payments. Dr Zion developed the SmartInsulin™ technology ...
#51. A glucose-responsive insulin therapy protects animals against ...
Zion TC, Lancaster TC, inventors; Smartcells, Inc., assignee. ... Nussbaum A. Merck Agrees to Purchase Insulin Maker SmartCells.
#52. Merck Research Laboratories - The Economic Times
merck research laboratories Latest Breaking News, Pictures, Videos, and Special Reports from The Economic ... Merck to acquire SmartCells for USD 500 mn.
#53. Review: Glucose-sensitive insulin - PMC - NCBI
It is conceivable that SmartCells/Merck had plans to initially test the concept in humans and planned to later address the pharmacokinetic issues, ...
#54. Smart Insulin
it to the next stage. And in 2010, the pharmaceutical company. Merck acquired SmartCells. The evolution of SmartCells is powerful validation of JDRF's.
#55. Merck to acquire SmartCells for $ 500 mn - Zee News
Drug-maker Merck & Co has announced that it will buy biotechnology company SmartCells for USD 500 million. Merck has a significant presence ...
#56. Review: Glucose-sensitive insulin. - Abstract - Europe PMC
It is conceivable that SmartCells/Merck had plans to initially test the concept in humans and planned to later address the pharmacokinetic issues, ...
#57. Merck & Co. kupuje SmartCells za 500 mil. USD - Fio banka
Výrobce léčiv Merck & Copany Incorporated se rozhodl koupit společnost SmartCells, která se zabývá léčbou cukrovky.
#58. Towards a smarter insulin - The Pharmaceutical Journal
There was news that SmartCells — a US start-up that had developed a candidate smart insulin drug — had been snapped up by drug giant Merck ...
#59. Akston starts small and likes it that way - BioWorld
Zion co-founded Smartcells Inc. in 2003 with technology developed at ... Smartinsulin, and sold it to Merck & Co. in what was at the time ...
#60. The key ingredient for medtech innovation - MassDevice
... company called SmartCells, secured funding and sold the company to Merck ... But for Zion, the most important ingredient in SmartCells' ...
#61. Neurimmune - PMLiVE
Phase Ib. 512. SmartCells/Merck. Glucose responsive insulin formulation. Preclinical. 500. Neurimmune/Biogen. Biogen targets neurodegenerative diseases. Biogen ...
#62. Smart Insulin - Diabetes UK
In 2011 US pharmaceutical company Merck acquired SmartCells. Their MK-2640 insulin is the first smart insulin to be tested on humans, with results still ...
#63. 7.4 Types of Innovation – Strategic Management
Pharmaceutical giant Merck obtained a foothold by purchasing SmartCells Inc.,—a company developing a possible new diabetes treatment.
#64. Merck rachète SmartCells, un laboratoire travaillant ... - Le Point
Le laboratoire pharmaceutique américain Merck a annoncé jeudi l'acquisition de SmartCells, un laboratoire de biotechnologies non coté ...
#65. Exhibit - SEC.gov
Laboratoires Merck Sharp & Dohme-Chibret ... Merck Global Health Innovation, Private Equity, LLC. Delaware ... SmartCells, Inc. Delaware. SOL Limited.
#66. Merck: What we Look for in a Licensing Partner
Merck acquires SmartCells, a company with self-regulating insulin technology. • SmartCells shareholders received an upfront payment.
#67. ACA, Angel Groups, and Angel-Backed Companies
Raysat Antenna Systems (Gilat Satellite. Networks). Sabal Medical (Swisslog). Shelfari (Amazon). SmartCells – (Merck). Trius Therapeutics (IPO).
#68. Insulin's second century - C&EN - American Chemical Society
Merck & Co. had a glucose-responsive insulin reach Phase 1 clinical trials. Merck acquired this program when it bought SmartCells, ...
#69. SmartCells Stock Price, Funding, Valuation ... - CB Insights
Evaluate their financials based on SmartCells's post-money valuation and revenue. ... Merck & Co. invested in SmartCells's Acquired funding round.
#70. 血糖応答性インスリン技術を持つSmartCells社を5億ドル相当 ...
海外発表、Merck社、血糖応答性インスリン技術を持つSmartCells社を5億ドル相当で買収 · Endicott Biofuels社とHolly Biofuels社、バイオディーゼル用 ...
#71. Akston Biosciences Leadership: Executives and Demographics
As SmartCells' President and CEO, Todd was instrumental in raising ... In December 2010, Merck and Co. acquired SmartCells for over $500M in ...
#72. 03 Merck : Top 20 Pharmaceutical Companies in 2011
03 Merck ... By Gil Roth07.14.11. #3: Merck. Headcount 94,000 ... What they said: “Through the acquisition of SmartCells we have obtained innovative ...
#73. Merck przejmie SmartCells - Rynek Aptek
Merck kupuje biotechnologiczną firmę SmartCells pracującą nad lekiem przeciwcukrzycowym. Transakcja, kolejne z serii przejęć biotechnologicznych ...
#74. Fireside Chat with Mic Williams (Founder of Boston Harbor ...
He has had several very successful exits with Smart Cells (Merck $500MM and Carbonite-IPO, Corbus Pharmaceuticals Holdings Inc.CRBP NASD,) There are more ...
#75. Merck, Staring at a Biotech Future, Seeks to Get in the Game ...
Like its competitors, Merck has aging blockbuster drugs losing patent ... Merck acquired recently from Cambridge, MA-based SmartCells.
#76. $27-$80/hr Merck Clinical Trials Jobs in Cambridge, MA
first clinical glucose-responsive insulin at SmartCells, Inc. (sold to Merck & Co.), Akston has ... Conduct GLP or clinical in vivo study sample analysis in ...
#77. Team - Inerjys
... RMI (acquired by Broadcom), Smartcells (acquired by Merck) and Watchfire (acquired by IBM). Recent successes include BLAZE.io's acquisition by Akamai, ...
#78. East Syracuse-Minoa graduate sells company, new method to ...
Merck & Co. pays up to $500 million for the company that's ... Greg M. Cooper/AP Todd Zion, co-founder and CEO of SmartCells Inc., ...
#79. Merck & Co., Inc. - AnnualReports.com
or distributed by Merck, its subsidiaries or affiliates, ... Alliance revenue represents Merck's share of profits, ... SmartCells, Inc.
#80. Chelsea Hewitt on Twitter: "@rofrechette @JNJInnovation ...
My first startup, 13 years ago, shared space with SmartCells (now. @Merck. ) in an Inotek lab, and we knew of dozens of other such Greater Boston ...
#81. The EnClear Team
Watson was Vice President of BD at SmartCells, Inc. where he negotiated the sale of the company to Merck & Co. for $500M in upfront and milestone payments.
#82. Akston Biosciences Strengthens Board with Addition of John T ...
Founded by the team that developed the world's first clinical glucose-responsive insulin at SmartCells, Inc. (sold to Merck & Co.) ...
#83. ANGEL INVESTORS - RESI Conference
As an angel investor, Mr. Arnold, has invested in, among others, SmartCells (sold to Merck), BioAssets development Corp (sold to Cephalon), ...
#84. 2022-2029 年全球干细胞库市场
Cryo-cell International; American CryoStem Corporation; ViaCord; Cord Blood Registry Systems; SmartCells, Inc.（Merck） ...
#85. <i>Journal of Diabetes</i> NEWS - Wiley Online Library
Merck and SmartCells signed a definitive agreement for Merck to acquire ... comparing Degludec to sitagliptin (Merck's Januvia) as an add-on therapy.
#86. Alan Watson VP Business Development - Kalion, Inc.
Watson was Vice President of Business Development at SmartCells, Inc. where he negotiated the sale of the company to Merck & Co. for $500M in upfront and ...
#87. Kalion, Inc. | Milton, MA, USA Startup - Gust
He also obtained an M.B.A. from Northeastern University. he negotiated the sale of SmartCells to Merck & Co. for $500M. Default avatar. Kristala Prather.
#88. WO2015051052A3 - Glucose-responsive insulin conjugates
Application filed by Merck Sharp & Dohme Corp. ... WO2010088294A1 * 2009-01-28 2010-08-05 Smartcells, Inc. Conjugate based systems for controlled drug ...
#89. 2019-Form-10-K-Final.pdf
In February 2020, Merck announced its intention to spin-off (the ... obtained in connection with the acquisition of SmartCells (see Note 8).
#90. Health Care | Benzinga
Merck Strikes Deal with SmartCells - Analyst Blog. Friday, December 3, 2010 - 11:16am | 667. Merck & Co., Inc. (MRK) recently announced an agreement that ...
#91. Life sciences intellectual property licensing at the ... - Gale
However, one particularly notable private deal was Merck's acquisition of SmartCells, founded by Todd Zion, an MIT chemical engineer.
#92. 美股週四盤中上揚 - 鉅亨
默克(MRK)與SmartCells宣佈雙方簽訂合併協議，默克將收購SmartCells，後者開發血糖反應胰島素配方，治療糖尿病患，默克將收購SmartCells所有 ...
#93. Entrepreneurial Impact: The Role of MIT — An Updated Report
No mention was made in Merck's press release of the royalty payments ... In December 2010, Merck acquired SmartCells for an upfront cash payment ...
#94. Akston ramps up efforts for room temperature COVID-19 vaccine
... by the team that developed the world's first clinical glucose-responsive insulin at SmartCells (which was sold to Merck & Co in 2010).
#95. Merck Eyes SmartCells Acqusition; Offer Could Top $500M
New Jersey-based pharmaceutical giant Merck & Co. (NYSE:MRK) is reportedly ready to pay over an estimated $500 million to acquire private ...
#96. Akston Biosciences - CipherBio
The company was founded in 2011 by the former SmartCells, Inc. team who developed the world's first clinical glucose-responsive insulin (acquired by Merck ...
smartcells merck 在 Juvenile Diabetes Cure Alliance- JDCA - Facebook 的推薦與評價
My nephew went to high school with a young man who was one of the first people in the trials. He LOVED it. That was when it was owned by SmartCells Inc. Merck ... ... <看更多>